Behçet’s Disease: An Overview of Etiopathogenesis
Behçet's disease (BD) is a systemic inflammatory disease with a chronic, relapsing-remitting course of unknown etiology hallmarked predominantly by mucocutaneous lesions and ocular involvement. BD shares some common features with autoimmune and autoinflammatory diseases and spondyloarthropathie...
Saved in:
Published in | Frontiers in immunology Vol. 10; p. 1067 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
10.05.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Behçet's disease (BD) is a systemic inflammatory disease with a chronic, relapsing-remitting course of unknown etiology hallmarked predominantly by mucocutaneous lesions and ocular involvement. BD shares some common features with autoimmune and autoinflammatory diseases and spondyloarthropathies (MHC-I-opathies). It is related to more than one pathogenic pathway triggered by environmental factors such as infectious agents in genetically predisposed subjects. The interplay between genetic background and immune system is linked to the BD presentation. Genetic factors have been investigated extensively, and several recent genome-wide association studies have confirmed
to be the strongest genetic susceptibility factor. However, new non-HLA susceptibility genes have been identified. Genetic variations in the genes encoding the cytokines could affect their function and be associated with disease susceptibility. Infectious agents such as
or the differences in salivary or gut microbiome composition can be considered to trigger the innate-derived inflammation, which is, subsequently, sustained by adaptive immune responses. Altered trimming of microbial and/or endogenous peptides by endoplasmic reticulum aminopeptidase 1 (ERAP1), presented by
, may play a key role in BD pathogenesis causing an alteration in T cell balance with downregulation of Tregs and expansion of Th1 and Th17. The activity of neutrophils is increased and there is an intense neutrophil infiltration in the early stage of inflammation in organs affected by the disease. Association with
and increased IL-17 response seems to have an important role in neutrophil activity. In this paper, we provide an overview of the most recent advances on BD etiopathogenesis. |
---|---|
AbstractList | Behçet's disease (BD) is a systemic inflammatory disease with a chronic, relapsing-remitting course of unknown etiology hallmarked predominantly by mucocutaneous lesions and ocular involvement. BD shares some common features with autoimmune and autoinflammatory diseases and spondyloarthropathies (MHC-I-opathies). It is related to more than one pathogenic pathway triggered by environmental factors such as infectious agents in genetically predisposed subjects. The interplay between genetic background and immune system is linked to the BD presentation. Genetic factors have been investigated extensively, and several recent genome-wide association studies have confirmed
to be the strongest genetic susceptibility factor. However, new non-HLA susceptibility genes have been identified. Genetic variations in the genes encoding the cytokines could affect their function and be associated with disease susceptibility. Infectious agents such as
or the differences in salivary or gut microbiome composition can be considered to trigger the innate-derived inflammation, which is, subsequently, sustained by adaptive immune responses. Altered trimming of microbial and/or endogenous peptides by endoplasmic reticulum aminopeptidase 1 (ERAP1), presented by
, may play a key role in BD pathogenesis causing an alteration in T cell balance with downregulation of Tregs and expansion of Th1 and Th17. The activity of neutrophils is increased and there is an intense neutrophil infiltration in the early stage of inflammation in organs affected by the disease. Association with
and increased IL-17 response seems to have an important role in neutrophil activity. In this paper, we provide an overview of the most recent advances on BD etiopathogenesis. Behçet's disease (BD) is a systemic inflammatory disease with a chronic, relapsing-remitting course of unknown etiology hallmarked predominantly by mucocutaneous lesions and ocular involvement. BD shares some common features with autoimmune and autoinflammatory diseases and spondyloarthropathies (MHC-I-opathies). It is related to more than one pathogenic pathway triggered by environmental factors such as infectious agents in genetically predisposed subjects. The interplay between genetic background and immune system is linked to the BD presentation. Genetic factors have been investigated extensively, and several recent genome-wide association studies have confirmed HLA-B*51 to be the strongest genetic susceptibility factor. However, new non-HLA susceptibility genes have been identified. Genetic variations in the genes encoding the cytokines could affect their function and be associated with disease susceptibility. Infectious agents such as Streptococcus sanguinis or the differences in salivary or gut microbiome composition can be considered to trigger the innate-derived inflammation, which is, subsequently, sustained by adaptive immune responses. Altered trimming of microbial and/or endogenous peptides by endoplasmic reticulum aminopeptidase 1 (ERAP1), presented by HLA-B*51, may play a key role in BD pathogenesis causing an alteration in T cell balance with downregulation of Tregs and expansion of Th1 and Th17. The activity of neutrophils is increased and there is an intense neutrophil infiltration in the early stage of inflammation in organs affected by the disease. Association with HLA-B*51 and increased IL-17 response seems to have an important role in neutrophil activity. In this paper, we provide an overview of the most recent advances on BD etiopathogenesis. Behçet's disease (BD) is a systemic inflammatory disease with a chronic, relapsing-remitting course of unknown etiology hallmarked predominantly by mucocutaneous lesions and ocular involvement. BD shares some common features with autoimmune and autoinflammatory diseases and spondyloarthropathies (MHC-I-opathies). It is related to more than one pathogenic pathway triggered by environmental factors such as infectious agents in genetically predisposed subjects. The interplay between genetic background and immune system is linked to the BD presentation. Genetic factors have been investigated extensively, and several recent genome-wide association studies have confirmed HLA-B*51 to be the strongest genetic susceptibility factor. However, new non-HLA susceptibility genes have been identified. Genetic variations in the genes encoding the cytokines could affect their function and be associated with disease susceptibility. Infectious agents such as Streptococcus sanguinis or the differences in salivary or gut microbiome composition can be considered to trigger the innate-derived inflammation, which is, subsequently, sustained by adaptive immune responses. Altered trimming of microbial and/or endogenous peptides by endoplasmic reticulum aminopeptidase 1 (ERAP1), presented by HLA-B*51, may play a key role in BD pathogenesis causing an alteration in T cell balance with downregulation of Tregs and expansion of Th1 and Th17. The activity of neutrophils is increased and there is an intense neutrophil infiltration in the early stage of inflammation in organs affected by the disease. Association with HLA-B*51 and increased IL-17 response seems to have an important role in neutrophil activity. In this paper, we provide an overview of the most recent advances on BD etiopathogenesis.Behçet's disease (BD) is a systemic inflammatory disease with a chronic, relapsing-remitting course of unknown etiology hallmarked predominantly by mucocutaneous lesions and ocular involvement. BD shares some common features with autoimmune and autoinflammatory diseases and spondyloarthropathies (MHC-I-opathies). It is related to more than one pathogenic pathway triggered by environmental factors such as infectious agents in genetically predisposed subjects. The interplay between genetic background and immune system is linked to the BD presentation. Genetic factors have been investigated extensively, and several recent genome-wide association studies have confirmed HLA-B*51 to be the strongest genetic susceptibility factor. However, new non-HLA susceptibility genes have been identified. Genetic variations in the genes encoding the cytokines could affect their function and be associated with disease susceptibility. Infectious agents such as Streptococcus sanguinis or the differences in salivary or gut microbiome composition can be considered to trigger the innate-derived inflammation, which is, subsequently, sustained by adaptive immune responses. Altered trimming of microbial and/or endogenous peptides by endoplasmic reticulum aminopeptidase 1 (ERAP1), presented by HLA-B*51, may play a key role in BD pathogenesis causing an alteration in T cell balance with downregulation of Tregs and expansion of Th1 and Th17. The activity of neutrophils is increased and there is an intense neutrophil infiltration in the early stage of inflammation in organs affected by the disease. Association with HLA-B*51 and increased IL-17 response seems to have an important role in neutrophil activity. In this paper, we provide an overview of the most recent advances on BD etiopathogenesis. Behçet's disease (BD) is a systemic inflammatory disease with a chronic, relapsing-remitting course of unknown etiology hallmarked predominantly by mucocutaneous lesions and ocular involvement. BD shares some common features with autoimmune and autoinflammatory diseases and spondyloarthropathies (MHC-I-opathies). It is related to more than one pathogenic pathway triggered by environmental factors such as infectious agents in genetically predisposed subjects. The interplay between genetic background and immune system is linked to the BD presentation. Genetic factors have been investigated extensively, and several recent genome-wide association studies have confirmed HLA-B * 51 to be the strongest genetic susceptibility factor. However, new non-HLA susceptibility genes have been identified. Genetic variations in the genes encoding the cytokines could affect their function and be associated with disease susceptibility. Infectious agents such as Streptococcus sanguinis or the differences in salivary or gut microbiome composition can be considered to trigger the innate-derived inflammation, which is, subsequently, sustained by adaptive immune responses. Altered trimming of microbial and/or endogenous peptides by endoplasmic reticulum aminopeptidase 1 (ERAP1), presented by HLA-B * 51 , may play a key role in BD pathogenesis causing an alteration in T cell balance with downregulation of Tregs and expansion of Th1 and Th17. The activity of neutrophils is increased and there is an intense neutrophil infiltration in the early stage of inflammation in organs affected by the disease. Association with HLA-B * 51 and increased IL-17 response seems to have an important role in neutrophil activity. In this paper, we provide an overview of the most recent advances on BD etiopathogenesis. |
Author | Alpsoy, Erkan Leccese, Pietro |
AuthorAffiliation | 2 Department of Dermatology and Venereology, School of Medicine, Akdeniz University , Antalya , Turkey 1 Rheumatology Institute of Lucania (IRel) and the Rheumatology Department of Lucania, San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera , Potenza , Italy |
AuthorAffiliation_xml | – name: 2 Department of Dermatology and Venereology, School of Medicine, Akdeniz University , Antalya , Turkey – name: 1 Rheumatology Institute of Lucania (IRel) and the Rheumatology Department of Lucania, San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera , Potenza , Italy |
Author_xml | – sequence: 1 givenname: Pietro surname: Leccese fullname: Leccese, Pietro – sequence: 2 givenname: Erkan surname: Alpsoy fullname: Alpsoy, Erkan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31134098$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kU1uFDEQhS0URELInhXqJZsZ_NdumwVSSAJEipQNrK1qu3rGUXd7sHsGseMaOQEH4SacBM9MghIkvLFVfu-rUr3n5GCMIxLyktG5ENq86cIwrOecMjOnjKrmCTliSsmZ4FwePHgfkpOcb2g50ggh6mfkUDAmJDX6iMj3uPz1E6ffP25zdR4yQsa31elYXW8wbQJ-q2JXXUwhrmBaxgWOmEN-QZ520Gc8ubuPyZcPF5_PPs2urj9enp1ezZxUfJoZMLWgnmOnJGgptQEqtOLAsNPeY82MBuV02-gWOkTZcsZU41vPpMdWi2Nyuef6CDd2lcIA6buNEOyuENPCQpqC69HWQjGvGyqUc5J1AIY1blvyBqXybWG927NW63ZA73CcEvSPoI9_xrC0i7ixquaCUlUAr-8AKX5dY57sELLDvocR4zpbzkUZn5atF-mrh73-NrlfexGovcClmHPCzrowQdnytnXoLaN2G7HdRWy3EdtdxMVI_zHes_9r-QOEJ6tU |
CitedBy_id | crossref_primary_10_3390_ijms24043160 crossref_primary_10_1002_jvc2_11 crossref_primary_10_1007_s10067_021_05817_1 crossref_primary_10_2139_ssrn_3903947 crossref_primary_10_3389_fimmu_2022_888763 crossref_primary_10_1016_j_intimp_2024_112122 crossref_primary_10_1186_s41927_024_00382_x crossref_primary_10_1080_09638288_2023_2283104 crossref_primary_10_1038_s41598_025_87130_4 crossref_primary_10_1016_j_clim_2023_109304 crossref_primary_10_1186_s43042_024_00605_3 crossref_primary_10_1111_bjd_20643 crossref_primary_10_1016_j_intimp_2022_108825 crossref_primary_10_3389_fcell_2021_758240 crossref_primary_10_1016_j_clim_2021_108854 crossref_primary_10_1016_j_semarthrit_2023_152224 crossref_primary_10_3389_fmolb_2021_797689 crossref_primary_10_1007_s10787_020_00701_x crossref_primary_10_1097_MD_0000000000031173 crossref_primary_10_1371_journal_pone_0227836 crossref_primary_10_1016_j_medcle_2022_08_009 crossref_primary_10_1016_j_nic_2023_07_007 crossref_primary_10_1055_a_2249_2116 crossref_primary_10_1016_j_clindermatol_2021_05_023 crossref_primary_10_1111_iji_12623 crossref_primary_10_1186_s12886_021_02222_9 crossref_primary_10_3390_jcm10215174 crossref_primary_10_3389_fimmu_2020_00358 crossref_primary_10_1080_00325481_2022_2159205 crossref_primary_10_3389_fimmu_2021_769785 crossref_primary_10_7759_cureus_68236 crossref_primary_10_1111_ijcp_14638 crossref_primary_10_1186_s13023_021_02056_0 crossref_primary_10_1007_s10753_023_01950_y crossref_primary_10_1016_j_intimp_2023_110128 crossref_primary_10_1097_RHU_0000000000001575 crossref_primary_10_3389_fmicb_2024_1416614 crossref_primary_10_2147_JEP_S265645 crossref_primary_10_1007_s40123_023_00767_0 crossref_primary_10_1111_dth_15616 crossref_primary_10_3389_fphar_2023_1110741 crossref_primary_10_1016_j_ajoc_2022_101630 crossref_primary_10_5114_reum_2022_117843 crossref_primary_10_1002_advs_202411524 crossref_primary_10_1097_GH9_0000000000000457 crossref_primary_10_3389_fmed_2021_624795 crossref_primary_10_1007_s40257_021_00609_4 crossref_primary_10_1093_rheumatology_kead101 crossref_primary_10_1111_dth_15585 crossref_primary_10_1007_s40674_020_00143_0 crossref_primary_10_1016_j_autrev_2020_102613 crossref_primary_10_1186_s13023_021_01772_x crossref_primary_10_1111_jdv_16454 crossref_primary_10_59213_TP_2024_169 crossref_primary_10_1097_MD_0000000000031277 crossref_primary_10_15789_1563_0625_EOH_2286 crossref_primary_10_3389_fimmu_2021_648341 crossref_primary_10_1590_1677_5449_20220036 crossref_primary_10_1007_s10238_023_01173_3 crossref_primary_10_1002_msc_1632 crossref_primary_10_1111_jop_13320 crossref_primary_10_3390_ijms21165803 crossref_primary_10_1080_14728214_2020_1847271 crossref_primary_10_1080_08830185_2020_1845330 crossref_primary_10_1186_s13075_022_02938_z crossref_primary_10_1007_s11910_020_01088_6 crossref_primary_10_1159_000510212 crossref_primary_10_1016_j_amsu_2020_03_010 crossref_primary_10_3389_fcell_2021_719235 crossref_primary_10_1002_wrna_1806 crossref_primary_10_3390_jcm11051278 crossref_primary_10_1080_09273948_2021_1889610 crossref_primary_10_2147_TCRM_S232660 crossref_primary_10_1055_a_1958_2338 crossref_primary_10_1080_03009742_2021_1885735 crossref_primary_10_21926_obm_genet_2403261 crossref_primary_10_1080_08820139_2021_1883647 crossref_primary_10_1111_tan_13880 crossref_primary_10_3390_ijms24033041 crossref_primary_10_3390_biomedicines11020624 crossref_primary_10_1007_s12026_024_09498_1 crossref_primary_10_1016_j_lfs_2024_122950 crossref_primary_10_3390_ijms25126697 crossref_primary_10_3390_medicina59122163 crossref_primary_10_47936_encephalitis_2020_00059 crossref_primary_10_1016_j_imlet_2021_04_008 crossref_primary_10_3389_fcell_2020_00818 crossref_primary_10_1002_eji_202250181 crossref_primary_10_1097_GH9_0000000000000463 crossref_primary_10_1186_s13075_024_03306_9 crossref_primary_10_1016_j_clim_2023_109631 crossref_primary_10_1155_2021_6626909 crossref_primary_10_1016_j_cyto_2020_154994 crossref_primary_10_3390_ijms242216382 crossref_primary_10_1093_rheumatology_keaa682 crossref_primary_10_3389_fimmu_2024_1361123 crossref_primary_10_1111_hel_12663 crossref_primary_10_1016_j_drudis_2021_11_020 crossref_primary_10_3389_fmed_2021_627192 crossref_primary_10_1007_s10067_021_05755_y crossref_primary_10_3389_fimmu_2019_02877 crossref_primary_10_3389_fimmu_2019_02755 crossref_primary_10_3389_fimmu_2021_724900 crossref_primary_10_1016_j_jconrel_2021_07_017 crossref_primary_10_3389_fmed_2021_695197 crossref_primary_10_1136_bcr_2019_232056 crossref_primary_10_23736_S2724_5683_21_05847_6 crossref_primary_10_1186_s12974_024_03123_6 crossref_primary_10_1080_09546634_2022_2062281 crossref_primary_10_1111_dth_13122 crossref_primary_10_1016_j_exer_2020_108045 crossref_primary_10_1080_1744666X_2021_1834853 crossref_primary_10_1016_j_medcli_2021_11_009 crossref_primary_10_1002_lipd_12398 crossref_primary_10_1007_s00726_022_03170_4 crossref_primary_10_3389_fphar_2022_912906 crossref_primary_10_1186_s13104_021_05767_6 crossref_primary_10_3389_fmolb_2022_831632 crossref_primary_10_1016_j_semarthrit_2020_05_017 crossref_primary_10_1111_1756_185X_14484 crossref_primary_10_1097_MD_0000000000018443 crossref_primary_10_1016_j_exer_2021_108618 crossref_primary_10_1097_RHU_0000000000001788 crossref_primary_10_3389_fmed_2021_713052 crossref_primary_10_3390_jcm11102938 crossref_primary_10_1016_j_autrev_2021_103016 crossref_primary_10_18481_2077_7566_2022_18_3_96_100 crossref_primary_10_1073_pnas_2204289119 |
Cites_doi | 10.3349/ymj.2012.53.1.35 10.1080/1547691X.2017.1346008 10.1038/ng.3786 10.1007/s00281-015-0502-8 10.1136/annrheumdis-2015-209059 10.1099/00222615-34-1-39 10.1902/jop.1999.70.12.1449 10.1002/art.37708 10.1016/j.autrev.2014.12.009 10.3748/wjg.v13.i21.2983 10.1155/2018/2405150 10.1111/j.1348-0421.1992.tb02083.x 10.1111/j.1468-3083.2008.02678.x 10.1186/1546-0096-11-S1-A184 10.1080/08820139.2017.1306865 10.1038/ng.625 10.1177/2040622314523062 10.1097/BOR.0000000000000003 10.12659/MSM.881720 10.1111/j.1365-2133.2007.08116.x 10.1007/s00296-003-0313-4 10.3349/ymj.1997.38.6.444 10.1038/ng.2551 10.4049/jimmunol.1501742 10.1136/annrheumdis-2011-200288 10.1111/j.1365-2133.2006.07348.x 10.1038/gene.2016.28 10.1167/iovs.07-1390 10.1111/j.1600-0714.2009.00765.x 10.1186/ar3005 10.2174/187152811795564109 10.1038/ng.2520 10.1016/j.imlet.2017.12.008 10.1093/rheumatology/keh311 10.1111/tan.13262 10.1016/j.autrev.2017.12.006 10.1016/j.molimm.2016.08.005 10.1002/art.20334 10.1002/art.39240 10.1016/j.autrev.2014.11.009 10.1073/pnas.1101262108 10.1038/jid.2010.114 10.1111/cei.13049 10.1016/j.jaut.2017.08.002 10.1038/nrrheum.2018.3 10.1038/ng.624 10.1007/s12328-014-0488-0 10.1016/j.clindermatol.2013.11.012 10.1155/2014/581468 10.1136/ard.59.8.622 10.4049/jimmunol.1300598 10.3109/08830189709116842 10.1111/1346-8138.13381 10.3109/09273948.2016.1158276 10.1016/j.jaut.2015.08.013 10.1097/MD.0000000000005516 10.1186/s13075-017-1435-5 10.1186/ar2695 10.1111/bjd.12128 10.1111/j.1365-2249.2011.04543.x 10.1161/CIRCULATIONAHA.115.017738 10.1038/s41598-017-09164-7 10.1093/rheumatology/keh236 10.1038/nrrheum.2015.147 10.1111/cei.12939 10.1111/j.1600-051X.2007.01085.x 10.3346/jkms.2017.32.1.33 10.1002/art.24642 10.1155/2017/1274960 10.1155/2018/4246965 10.1016/j.biopha.2017.04.106 10.1016/j.autrev.2011.11.026 10.1016/j.clim.2016.06.002 10.1097/BOR.0000000000000189 10.1074/jbc.M117.789180 |
ContentType | Journal Article |
Copyright | Copyright © 2019 Leccese and Alpsoy. 2019 Leccese and Alpsoy |
Copyright_xml | – notice: Copyright © 2019 Leccese and Alpsoy. 2019 Leccese and Alpsoy |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM DOA |
DOI | 10.3389/fimmu.2019.01067 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Open Access Full Text |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1664-3224 |
ExternalDocumentID | oai_doaj_org_article_5361d87036cc41faa917c61d8d9e46db PMC6523006 31134098 10_3389_fimmu_2019_01067 |
Genre | Journal Article Review |
GroupedDBID | 53G 5VS 9T4 AAFWJ AAKDD AAYXX ACGFO ACGFS ACXDI ADBBV ADRAZ AENEX AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK EBS EMOBN GROUPED_DOAJ GX1 HYE KQ8 M48 M~E OK1 PGMZT RNS RPM CGR CUY CVF ECM EIF IAO IEA IHR IHW IPNFZ NPM RIG 7X8 5PM |
ID | FETCH-LOGICAL-c462t-9a9530d2ef64a84489a03862a1ef8dde5198a6c8b78bafee4b21167dbd14deb83 |
IEDL.DBID | M48 |
ISSN | 1664-3224 |
IngestDate | Wed Aug 27 01:07:31 EDT 2025 Thu Aug 21 18:36:45 EDT 2025 Fri Jul 11 15:10:05 EDT 2025 Thu Jan 02 22:59:06 EST 2025 Thu Apr 24 23:05:00 EDT 2025 Tue Jul 01 00:39:34 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | infectious agents Behçet's disease genetics immunology etiology |
Language | English |
License | This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c462t-9a9530d2ef64a84489a03862a1ef8dde5198a6c8b78bafee4b21167dbd14deb83 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 Edited by: Angelo Valerio Marzano, University of Milan, Italy Reviewed by: Giacomo Emmi, University of Florence, Italy; Fiona Moghaddas, Walter and Eliza Hall Institute of Medical Research, Australia This article was submitted to Autoimmune and Autoinflammatory Disorders, a section of the journal Frontiers in Immunology |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fimmu.2019.01067 |
PMID | 31134098 |
PQID | 2232110664 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_5361d87036cc41faa917c61d8d9e46db pubmedcentral_primary_oai_pubmedcentral_nih_gov_6523006 proquest_miscellaneous_2232110664 pubmed_primary_31134098 crossref_citationtrail_10_3389_fimmu_2019_01067 crossref_primary_10_3389_fimmu_2019_01067 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2019-05-10 |
PublicationDateYYYYMMDD | 2019-05-10 |
PublicationDate_xml | – month: 05 year: 2019 text: 2019-05-10 day: 10 |
PublicationDecade | 2010 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland |
PublicationTitle | Frontiers in immunology |
PublicationTitleAlternate | Front Immunol |
PublicationYear | 2019 |
Publisher | Frontiers Media S.A |
Publisher_xml | – name: Frontiers Media S.A |
References | Akman (B26) 2008; 22 Guasp (B53) 2017; 292 Mumcu (B18) 2004; 43 Ombrello (B49) 2015; 27 Puccetti (B64) 2018; 2018 de Menthon (B33) 2009; 61 Suzuki (B75) 1992; 19 Hamzaoui (B79) 2011; 17 Emmi (B83) 2016; 95 Alpsoy (B1) 2016; 43 Studd (B11) 1991; 34 Lee (B36) 2013; 72 Lehner (B9) 1997; 14 Takeuchi (B43) 2017; 49 Onen (B27) 2003; 23 Giza (B52) 2018; 191 Touzot (B84) 2015; 14 Shimizu (B77) 2012; 168 Becatti (B69) 2016; 33 Chi (B78) 2008; 49 Mizushima (B20) 1988; 15 Consolandi (B32) 2015; 14 Kirino (B37) 2013; 45 Abdolmohammadi (B56) 2017; 32 Takeuchi (B59) 2015; 64 Karacayli (B24) 2009; 38 López de Castro (B48) 2016; 77 Yazici (B8) 2018; 14 Sousa (B58) 2015; 67 Pineton de Chambrun (B29) 2012; 11 Hasan (B72) 2017; 188 Mat (B61) 2014; 32 Gul (B34) 2010; 59 Alpsoy (B2) 2007; 157 Puccetti (B65) 2018; 2018 Ben Ahmed (B76) 2004; 50 Gul (B35) 2014; 26 Kochan (B51) 2011; 108 (B3) 1990; 335 Eksioglu-Demiralp (B68) 2001; 19 Kaneko (B19) 1997; 38 Burillo-Sanz (B62) 2017; 7 Hatemi (B6) 2017; 35 Hou (B38) 2012; 64 Celenligil-Nazliel (B23) 1999; 70 Fei (B41) 2009; 11 Cho (B16) 2010; 28 Hughes (B42) 2013; 45 Yavuz (B71) 2016; 17 Reeves (B50) 2013; 191 Yamaguchi (B73) 2010; 12 Behçet (B10) 1937; 105 Salmaninejad (B45) 2017; 14 Lule (B15) 2017; 84 Togashi (B12) 2011; 10 Cho (B14) 2012; 53 Akman (B22) 2007; 34 Deniz (B67) 2017; 46 Cho (B17) 2013; 168 Sakoda (B81) 2016; 196 Gul (B4) 2015; 37 Perazzio (B70) 2015; 33 Kaneko (B25) 2014; 581468 Huang (B44) 2017; 2017 Kang (B55) 2017; 19 Alpsoy (B21) 2005; 23 Padula (B46) 2018; 2018 Greco (B7) 2018; 17 Ersoy (B28) 2007; 13 Akman (B57) 2006; 155 Ekinci (B80) 2010; 130 Alipour (B63) 2017; 91 Esatoglu (B85) 2016; 34 Hisamatsu (B60) 2014; 7 Zhou (B66) 2013; 11 Treusch (B74) 2004; 43 Takeuchi (B47) 2016; 75 Takeuchi (B82) 2017; 25 McGonagle (B5) 2015; 11 Coit (B31) 2016; 169 Mizuki (B39) 2010; 42 Remmers (B40) 2010; 42 Saleh (B30) 2014; 5 Yokota (B13) 1992; 36 Afkari (B54) 2018; 194 |
References_xml | – volume: 53 start-page: 35 year: 2012 ident: B14 article-title: New insights in the clinical understanding of Behçet's disease publication-title: Yonsei Med J doi: 10.3349/ymj.2012.53.1.35 – volume: 14 start-page: 137 year: 2017 ident: B45 article-title: Genetics and immunodysfunction underlying Behçet's disease and immunomodulant treatment approaches publication-title: J Immunotoxicol doi: 10.1080/1547691X.2017.1346008 – volume: 335 start-page: 1078 year: 1990 ident: B3 article-title: Criteria for diagnosis of Behçet's disease publication-title: Lancet. – volume: 49 start-page: 438 year: 2017 ident: B43 article-title: Dense genotyping of immune-related loci implicates host responses to microbial exposure in Behçet's disease susceptibility publication-title: Nat Genet doi: 10.1038/ng.3786 – volume: 37 start-page: 413 year: 2015 ident: B4 article-title: Pathogenesis of Behçet's disease: autoinflammatory features and beyond publication-title: Semin Immunopathol doi: 10.1007/s00281-015-0502-8 – volume: 75 start-page: 2208 year: 2016 ident: B47 article-title: A single endoplasmic reticulum aminopeptidase-1 protein allotype is a strong risk factor for Behçet's disease in HLA-B*51 carriers publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2015-209059 – volume: 34 start-page: 39 year: 1991 ident: B11 article-title: Detection of HSV-1 DNA in patients with Behçet's syndrome and in patients with recurrent oral ulcers by the polymerase chain reaction publication-title: J Med Microbiol doi: 10.1099/00222615-34-1-39 – volume: 35 start-page: 5 year: 2017 ident: B6 article-title: Behçet's disease: an MHC-I-opathy? publication-title: Clin Exp Rheumatol – volume: 70 start-page: 1449 year: 1999 ident: B23 article-title: Periodontal findings and systemic antibody responses to oral microorganisms in Behçet's disease publication-title: J Periodontol. doi: 10.1902/jop.1999.70.12.1449 – volume: 64 start-page: 4104 year: 2012 ident: B38 article-title: Identification of a susceptibility locus in STAT4 for Behçet‘s disease in Han Chinese in a genome-wide association study publication-title: Arthritis Rheum doi: 10.1002/art.37708 – volume: 14 start-page: 370 year: 2015 ident: B84 article-title: IFNa induces IL-10 production and tilt the balance between Th1 and Th17 in Behçet disease publication-title: Autoimmun Rev doi: 10.1016/j.autrev.2014.12.009 – volume: 13 start-page: 2983 year: 2007 ident: B28 article-title: H pylori infection in patients with Behçet's disease publication-title: World J Gastroenterol doi: 10.3748/wjg.v13.i21.2983 – volume: 2018 start-page: 2405150 year: 2018 ident: B65 article-title: MicroRNA expression profiling in Behçet's disease publication-title: J Immunol Res doi: 10.1155/2018/2405150 – volume: 36 start-page: 815 year: 1992 ident: B13 article-title: Antibody response to oral streptococci in Behcet's disease publication-title: Microbiol Immunol doi: 10.1111/j.1348-0421.1992.tb02083.x – volume: 22 start-page: 950 year: 2008 ident: B26 article-title: Relationship between periodontal findings and the TNF-alpha Gene 1031T/C polymorphism in Turkish patients with Behçet's disease publication-title: J Eur Acad Dermatol Venereol. doi: 10.1111/j.1468-3083.2008.02678.x – volume: 11 start-page: A184 year: 2013 ident: B66 article-title: OR9-001 - Exome sequencing in monogenic Behçet-like disease publication-title: Pediatr Rheumatol Online J doi: 10.1186/1546-0096-11-S1-A184 – volume: 46 start-page: 518 year: 2017 ident: B67 article-title: Th17-Inducing conditions lead to in vitro activation of both Th17 and Th1 responses in Behçet's disease publication-title: Immunol Invest doi: 10.1080/08820139.2017.1306865 – volume: 42 start-page: 698 year: 2010 ident: B40 article-title: Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's disease publication-title: Nat Genet doi: 10.1038/ng.625 – volume: 5 start-page: 112 year: 2014 ident: B30 article-title: Update on the therapy of Behçet disease publication-title: Ther Adv Chronic Dis doi: 10.1177/2040622314523062 – volume: 26 start-page: 56 year: 2014 ident: B35 article-title: Genetics of Behçet's disease: lessons learned from genomewide association studies publication-title: Curr Opin Rheumatol doi: 10.1097/BOR.0000000000000003 – volume: 17 start-page: CR227 year: 2011 ident: B79 article-title: Expression of Th-17 and RORγt mRNA in Behçet's Disease publication-title: Med Sci Monit doi: 10.12659/MSM.881720 – volume: 157 start-page: 901 year: 2007 ident: B2 article-title: Clinical features and natural course of Behcet's disease in 661 cases: a multicentre study publication-title: Br J Dermatol doi: 10.1111/j.1365-2133.2007.08116.x – volume: 23 start-page: 289 year: 2003 ident: B27 article-title: Seroprevalence of Borrelia burgdorferi in patients with Behçet's disease publication-title: Rheumatol Int doi: 10.1007/s00296-003-0313-4 – volume: 38 start-page: 444 year: 1997 ident: B19 article-title: Streptococcal infection in the pathogenesis of Behçet's disease and clinical effects of minocycline on the disease symptoms publication-title: Yonsei Med J doi: 10.3349/ymj.1997.38.6.444 – volume: 45 start-page: 319 year: 2013 ident: B42 article-title: Identification of multiple independent susceptibility loci in the HLA region in Behçet's disease publication-title: Nat Genet doi: 10.1038/ng.2551 – volume: 196 start-page: 2947 year: 2016 ident: B81 article-title: Pathogenic function of herpesvirus entry mediator in experimental autoimmune uveitis by induction of Th1- and Th17-type T cell responses publication-title: J Immunol doi: 10.4049/jimmunol.1501742 – volume: 72 start-page: 1510 year: 2013 ident: B36 article-title: Genome-wide association study identifies GIMAP as a novel susceptibility locus for Behçet's disease publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2011-200288 – volume: 155 start-page: 350 year: 2006 ident: B57 article-title: TNF-alpha gene 1031 T/C polymorphism in Turkish patients with Behçet's disease publication-title: Br J Dermatol doi: 10.1111/j.1365-2133.2006.07348.x – volume: 17 start-page: 335 year: 2016 ident: B71 article-title: Dual effects of testosterone in Behçet's disease: implications for a role in disease pathogenesis publication-title: Genes Immun doi: 10.1038/gene.2016.28 – volume: 49 start-page: 3058 year: 2008 ident: B78 article-title: Upregulated IL-23 and IL-17 in Behçet patients with active uveitis publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.07-1390 – volume: 38 start-page: 410 year: 2009 ident: B24 article-title: The close association between dental and periodontal treatments and oral ulcer course in Behçet's disease: a prospective clinical study publication-title: J Oral Pathol Med. doi: 10.1111/j.1600-0714.2009.00765.x – volume: 12 start-page: R80 year: 2010 ident: B73 article-title: Natural killer cells control a T-helper 1 response in patients with Behçet's disease publication-title: Arthritis Res Ther doi: 10.1186/ar3005 – volume: 10 start-page: 164 year: 2011 ident: B12 article-title: Skin prick test with self-saliva in patients with oral aphthoses: a diagnostic pathergy for Behcet's disease and recurrent aphthosis publication-title: Inflamm Allergy Drug Targets doi: 10.2174/187152811795564109 – volume: 45 start-page: 202 year: 2013 ident: B37 article-title: Genome-wide association analysis identifies new susceptibility loci for Behçet's disease and epistasis between HLA-B-51 and ERAP1 publication-title: Nat Genet doi: 10.1038/ng.2520 – volume: 194 start-page: 56 year: 2018 ident: B54 article-title: Molecular analysis of interleukin-10 gene polymorphisms in patients with Behçet's disease publication-title: Immunol Lett doi: 10.1016/j.imlet.2017.12.008 – volume: 43 start-page: 1275 year: 2004 ident: B74 article-title: Influence of human recombinant interferon-alpha2a (rhIFN-alpha2a) on altered lymphocyte subpopulations and monocytes in Behçet's disease publication-title: Rheumatology doi: 10.1093/rheumatology/keh311 – volume: 2018 start-page: 13262 year: 2018 ident: B46 article-title: ERAP1 molecular characterization: identification of a de novo allelic variant publication-title: HLA doi: 10.1111/tan.13262 – volume: 33 start-page: S85 year: 2015 ident: B70 article-title: Behçet's disease heterogeneity: cytokine production and oxidative burst of phagocytes are altered in patients with severe manifestations publication-title: Clin Exp Rheumatol – volume: 17 start-page: 567 year: 2018 ident: B7 article-title: Behçet's disease: New insights into pathophysiology, clinical features and treatment options publication-title: Autoimmun Rev doi: 10.1016/j.autrev.2017.12.006 – volume: 77 start-page: 193 year: 2016 ident: B48 article-title: Molecular and pathogenic effects of endoplasmic reticulum aminopeptidases ERAP1 and ERAP2 in MHC-I-associated inflammatory disorders: towards a unifying view publication-title: Mol Immunol doi: 10.1016/j.molimm.2016.08.005 – volume: 50 start-page: 2291 year: 2004 ident: B76 article-title: Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions of Behçet's disease publication-title: Arthritis Rheum doi: 10.1002/art.20334 – volume: 34 start-page: 3 year: 2016 ident: B85 article-title: Highlights of the 17th International Conference on Behçet's syndrome publication-title: Clin Exp Rheumatol – volume: 67 start-page: 2742 year: 2015 ident: B58 article-title: Brief report: association of CCR1, KLRC4, IL12A-AS1, STAT4, and ERAP1 With Behçet's disease in Iranians publication-title: Arthritis Rheumatol doi: 10.1002/art.39240 – volume: 14 start-page: 269 year: 2015 ident: B32 article-title: Behcet's syndrome patients exhibit specific microbiome signature publication-title: Autoimmun Rev doi: 10.1016/j.autrev.2014.11.009 – volume: 108 start-page: 7745 year: 2011 ident: B51 article-title: Crystal structures of the endoplasmic reticulum aminopeptidase-1 (ERAP1) reveal the molecular basis for N-terminal peptide trimming publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1101262108 – volume: 130 start-page: 2136 year: 2010 ident: B80 article-title: IL-17A has an important role in the acute attacks of Behçet's disease publication-title: J Invest Dermatol doi: 10.1038/jid.2010.114 – volume: 191 start-page: 11 year: 2018 ident: B52 article-title: Is Behçet's disease a ‘class 1-opathy’? publication-title: Clin Exp Immunol doi: 10.1111/cei.13049 – volume: 84 start-page: 87 year: 2017 ident: B15 article-title: Behçet Disease serum is immunoreactive to neurofilament medium which share common epitopes to bacterial HSP-65, a putative trigger publication-title: J Autoimmun. doi: 10.1016/j.jaut.2017.08.002 – volume: 19 start-page: 588 year: 1992 ident: B75 article-title: Increased peripheral blood gamma delta1 T cells and natural killer cells in Behçet's disease publication-title: J Rheumatol – volume: 19 start-page: S19 year: 2001 ident: B68 article-title: Neutrophil activation in Behçet's disease publication-title: Clin Exp Rheumatol. – volume: 14 start-page: 119 year: 2018 ident: B8 article-title: Behçet syndrome: a contemporary view publication-title: Nat Rev Rheumatol doi: 10.1038/nrrheum.2018.3 – volume: 42 start-page: 703 year: 2010 ident: B39 article-title: Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci publication-title: Nat Genet doi: 10.1038/ng.624 – volume: 7 start-page: 205 year: 2014 ident: B60 article-title: Diagnosis and management of intestinal Behçet's disease publication-title: Clin J Gastroenterol doi: 10.1007/s12328-014-0488-0 – volume: 28 start-page: S31 year: 2010 ident: B16 article-title: Identification of streptococcal proteins reacting with sera from Behçet's disease and rheumatic disorders publication-title: Clin Exp Rheumatol – volume: 32 start-page: 435 year: 2014 ident: B61 article-title: Behçet's disease as a systemic disease publication-title: Clin Dermatol doi: 10.1016/j.clindermatol.2013.11.012 – volume: 581468 year: 2014 ident: B25 article-title: A new diagnostic way for Behçet's disease: skin prick with self-saliva publication-title: Genet Res Int doi: 10.1155/2014/581468 – volume: 59 start-page: 622 year: 2010 ident: B34 article-title: Familial aggregation of Behçet's disease in Turkey publication-title: Ann Rheum Dis doi: 10.1136/ard.59.8.622 – volume: 23 start-page: 532 year: 2005 ident: B21 article-title: Behçet's disease: treatment of mucocutaneous lesions publication-title: Clin Exp Rheumatol – volume: 191 start-page: 35 year: 2013 ident: B50 article-title: Naturally occurring ERAP1 haplotypes encode functionally distinct alleles with fine substrate specificity publication-title: J Immunol doi: 10.4049/jimmunol.1300598 – volume: 14 start-page: 21 year: 1997 ident: B9 article-title: The role of heat shock protein, microbial and autoimmune agents in the aetiology of Behçet's disease publication-title: Int Rev Immunol. doi: 10.3109/08830189709116842 – volume: 43 start-page: 620 year: 2016 ident: B1 article-title: Behçet's disease: A comprehensive review with a focus on epidemiology, etiology and clinical features, and management of mucocutaneous lesions publication-title: J Dermatol doi: 10.1111/1346-8138.13381 – volume: 15 start-page: 1029 year: 1988 ident: B20 article-title: Induction of Behçet's disease symptoms after dental treatment and streptococcal antigen skin test publication-title: J Rheumatol – volume: 105 start-page: 1152 year: 1937 ident: B10 article-title: Uber rezidivierende aphthose, durch ein Virus verursachte Geschwure, am Mund, am Auge, und an den Genitalien publication-title: Dermatol Wochenschr – volume: 25 start-page: 52 year: 2017 ident: B82 article-title: Analysis of Th cell-related cytokine production in Behçet disease patients with uveitis before and after infliximab treatment publication-title: Ocul Immunol Inflamm doi: 10.3109/09273948.2016.1158276 – volume: 64 start-page: 137 year: 2015 ident: B59 article-title: The immunogenetics of Behçet's disease: a comprehensive review publication-title: J Autoimmun doi: 10.1016/j.jaut.2015.08.013 – volume: 95 start-page: 49 year: 2016 ident: B83 article-title: Cytotoxic Th1 and Th17 cells infiltrate the intestinal mucosa of Behcet patients and exhibit high levels of TNF-α in early phases of the disease publication-title: Medicine. doi: 10.1097/MD.0000000000005516 – volume: 19 start-page: 227 year: 2017 ident: B55 article-title: Behçet's disease risk association fine-mapped on the IL23R-IL12RB2 intergenic region in Koreans publication-title: Arthritis Res Ther doi: 10.1186/s13075-017-1435-5 – volume: 11 start-page: R66 year: 2009 ident: B41 article-title: Identification of novel genetic susceptibility loci for Behçet's disease using a genome-wide association study publication-title: Arthritis Res Ther doi: 10.1186/ar2695 – volume: 168 start-page: 977 year: 2013 ident: B17 article-title: Serum IgA reactivity against GroEL of Streptococcus sanguinis and human heterogeneous nuclear ribonucleoprotein A2/B1 in patients with Behçet disease publication-title: Br J Dermatol doi: 10.1111/bjd.12128 – volume: 168 start-page: 68 year: 2012 ident: B77 article-title: Excessive CD4+ T cells co-expressing interleukin-17 and interferon-γ in patients with Behçet's disease publication-title: Clin Exp Immunol doi: 10.1111/j.1365-2249.2011.04543.x – volume: 33 start-page: 302 year: 2016 ident: B69 article-title: Neutrophil activation promotes fibrinogen oxidation and thrombus formation in Behçet disease publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.115.017738 – volume: 7 start-page: 8453 year: 2017 ident: B62 article-title: Mutational profile of rare variants in inflammasome-related genes in Behçet disease: a next generation sequencing approach publication-title: Sci Rep doi: 10.1038/s41598-017-09164-7 – volume: 43 start-page: 1028 year: 2004 ident: B18 article-title: Oral health is impaired in Behçet's disease and is associated with disease severity publication-title: Rheumatology doi: 10.1093/rheumatology/keh236 – volume: 11 start-page: 731 year: 2015 ident: B5 article-title: ‘MHC-I-opathy’-unified concept for spondyloarthritis and Behçet disease publication-title: Nat Rev Rheumatol doi: 10.1038/nrrheum.2015.147 – volume: 188 start-page: 311 year: 2017 ident: B72 article-title: Circulating NK cells and their subsets in Behçet's disease publication-title: Clin Exp Immunol doi: 10.1111/cei.12939 – volume: 34 start-page: 485 year: 2007 ident: B22 article-title: Relationship between periodontal findings and Behçet's disease: a controlled study publication-title: J Clin Periodontol. doi: 10.1111/j.1600-051X.2007.01085.x – volume: 32 start-page: 33 year: 2017 ident: B56 article-title: Polymorphisms of promoter region of TNF-α gene in iranian azeri turkish patients with Behçet's disease publication-title: J Korean Med Sci doi: 10.3346/jkms.2017.32.1.33 – volume: 61 start-page: 1287 year: 2009 ident: B33 article-title: HLA-B51/B5 and the risk of Behçet's disease: a systematic review and meta-analysis of case-control genetic association studies publication-title: Arthritis Rheum doi: 10.1002/art.24642 – volume: 2017 start-page: 1274960 year: 2017 ident: B44 article-title: The association of chemokine gene polymorphisms with VKH and Behçet's disease in a chinese han population publication-title: Biomed Res Int doi: 10.1155/2017/1274960 – volume: 2018 start-page: 4246965 year: 2018 ident: B64 article-title: Gene expression profiling in Behçet's disease indicates an autoimmune component in the pathogenesis of the disease and opens new avenues for targeted therapy publication-title: J Immunol Res doi: 10.1155/2018/4246965 – volume: 91 start-page: 526 year: 2017 ident: B63 article-title: Epigenetic alterations in chronic disease focusing on Behçet's disease: review publication-title: Biomed Pharmacother doi: 10.1016/j.biopha.2017.04.106 – volume: 11 start-page: 687 year: 2012 ident: B29 article-title: New insights into the pathogenesis of Behçet's disease publication-title: Autoimmun Rev doi: 10.1016/j.autrev.2011.11.026 – volume: 169 start-page: 28 year: 2016 ident: B31 article-title: Sequencing of 16S rRNA reveals a distinct salivary microbiome signature in Behcet's disease publication-title: Clin Immunol doi: 10.1016/j.clim.2016.06.002 – volume: 27 start-page: 349 year: 2015 ident: B49 article-title: Endoplasmic reticulum-associated amino-peptidase 1 and rheumatic disease: genetics publication-title: Curr Opin Rheumatol doi: 10.1097/BOR.0000000000000189 – volume: 292 start-page: 9680 year: 2017 ident: B53 article-title: The Behçet's disease-associated variant of the aminopeptidase ERAP1 shapes a low-affinity HLA-B*51 peptidome by differential subpeptidome processing publication-title: J Biol Chem doi: 10.1074/jbc.M117.789180 |
SSID | ssj0000493335 |
Score | 2.5559278 |
SecondaryResourceType | review_article |
Snippet | Behçet's disease (BD) is a systemic inflammatory disease with a chronic, relapsing-remitting course of unknown etiology hallmarked predominantly by... |
SourceID | doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 1067 |
SubjectTerms | Aminopeptidases - metabolism Behcet Syndrome - genetics Behcet Syndrome - immunology Behcet Syndrome - pathology Behçet's disease etiology Genetic Predisposition to Disease - genetics Genetic Variation - genetics genetics HLA-B Antigens - genetics Humans Immunology infectious agents Interleukin-17 - genetics Interleukin-17 - metabolism Minor Histocompatibility Antigens - metabolism Neutrophil Infiltration - immunology Neutrophils - immunology Streptococcus - immunology Streptococcus sanguis T-Lymphocytes, Regulatory - immunology Th1 Cells - immunology Th17 Cells - immunology |
SummonAdditionalLinks | – databaseName: DOAJ Open Access Full Text dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbhMxELaqSEi9VBRKWVqqReqFw5L12ut4uSUlUVSp7YVIuVn-WxJEN4gkrXrjNXgCHoQ34UmYsZMoQQguXL221vrGOzPfjvUNIecFl4wWrsi4dDbjLjcZRDmfFR1Jba6BNod2PlfXYjjil-NyvNXqC--ERXngCFy7ZII6iTJR1nJaaw38wuKQqzwXzqD3hZi3RaY-xryXMVbGuiSwsKpdT29vl3iVq3oTZNN24lCQ6_9Tjvn7Vcmt2DN4TA5WSWPajZs9JHu-eUIexTaSD08J7_nJj-9-8fPrt3n6LlZc3qbdJr25Q0_g79NZnfbBAth-ePYBvdt0fkRGg_77i2G26oaQWS6KRVbpqmS5K3wtuJbAqiqdM-AjmvpagpOCVExqYaXpSKNr77kpsMbijKPceSPZM9JqZo1_TtLKUgoLuPSWca2LSlOTewAT23XW0iakvcZG2ZVUOHas-KSAMiCaKqCpEE0V0EzI682Kz1Em4y9zewj3Zh4KXIcBMLtamV39y-wJebU2loIPAqscuvGz5VxBvoOkVgiekONovM2rGKUMCK1MSGfHrDt72X3STCdBdFvg7_NcvPgfmz8h-whHFkRgT0lr8WXpX0JuszBn4Rj_Aus2-NQ priority: 102 providerName: Directory of Open Access Journals |
Title | Behçet’s Disease: An Overview of Etiopathogenesis |
URI | https://www.ncbi.nlm.nih.gov/pubmed/31134098 https://www.proquest.com/docview/2232110664 https://pubmed.ncbi.nlm.nih.gov/PMC6523006 https://doaj.org/article/5361d87036cc41faa917c61d8d9e46db |
Volume | 10 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELZKKyQuiDcpUAUJCXFwGz_W6yChqoWWCqlwYaW9WX6lXdQmdB8t_UX8EP5YZ5x0YatVxSUHx06ceXjm8zgzhLzhUgvGA6dSB09lKBwFKxcp72vmCwuwOZXzOfyqDgbyy7A3_Pt7dEfAyVJoh_WkBuOTzV9nl9ug8B8QcYK93apGp6czPKVVbqaMaHfIGtilPqrpYefs_2h9YSFSxU2mlKQgybKNWy59yIKdSun8l_mgN49S_mOb9h-Q-51Tme-0UvCQrMT6Ebnblpm8fEz4bjz-8ztO307yT2085n2-U-ffznGdiBd5U-V7wB8sTtwc4do3mjwhg_297x8PaFcrgXqp-JSWtuyJIvBYKWk1YK7SFgLQimWx0rCEgaOmrfLa9bWzVYzScYzABBeYDNFp8ZSs1k0dn5O89IzBAKmjF9JaXlrmiqiCw2KelfYZ2bqmjPFdInGsZ3FiAFAgLU2ipUFamkTLjLybj_jZJtG4pe8uEnveD9Nfp4ZmfGQ6bTI9oVjQmDvMe8kqawF0emwKZZQw04y8vmaVAXXBGIitYzObGPCGEPKCAGTkWcu6-asEYwLgrs5If4GpC3NZvFOPjlNKboWb64Va_4_3viD38GtpygD7kqxOx7P4ChybqdtIGwJw_TxkG0l2rwAvKPfC |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Beh%C3%A7et%27s+Disease%3A+An+Overview+of+Etiopathogenesis&rft.jtitle=Frontiers+in+immunology&rft.au=Leccese%2C+Pietro&rft.au=Alpsoy%2C+Erkan&rft.date=2019-05-10&rft.issn=1664-3224&rft.eissn=1664-3224&rft.volume=10&rft.spage=1067&rft_id=info:doi/10.3389%2Ffimmu.2019.01067&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-3224&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-3224&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-3224&client=summon |